Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF InhibitionHélène Salmon, Miriam Mérad, Judith Agudo et al.|Immunity|2016Cited by 1.2k
BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma modelDaniele Perna, David J. Adams, Florian A. Karreth et al.|Proceedings of the National Academy of Sciences|2015Cited by 143
Isolation and Molecular Characterization of Circulating Melanoma CellsXi Luo, Daniel A. Haber, Devarati Mitra et al.|Cell Reports|2014Cited by 109
Siah2 control of T-regulatory cells limits anti-tumor immunityMarzia Scortegagna, Ze’ev A. Ronai, Kathryn Hockemeyer et al.|Nature Communications|2020Cited by 30